Coordinated expression of MDM2, CDK4 and HMGI-C in atypical lipomatous tumors

被引：0
|
作者：
Dei Tos, AP
Doglioni, C
Piccinin, S
Furlanetto, A
Sciot, R
Dal Cin, P
Boiocchi, M
Fletcher, CDM
Tallini, G
机构：
[1] Treviso Reg Hosp, Dept Pathol, Treviso, Italy
[2] Hosp Belluno, Dept Pathol, Belluno, Italy
[3] Catholic Univ Louvain, Ctr Human Genet, Dept Pathol, B-3000 Louvain, Belgium
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Yale Univ, Dept Pathol, New Haven, CT 06520 USA
[6] Exp Oncol 1, Aviano, Italy
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：8A / 8A
页数：1
相关论文
共 50 条
  • [1] Coordinated expression of MDM2, CDK4 and HMGI-C in atypical lipomatous tumors.
    Dei Tos, AP
    Doglioni, C
    Piccinin, S
    Furlanetto, A
    Sciot, R
    Dal Cin, P
    Boiocchi, M
    Fletcher, CDM
    Tallini, G
    [J]. LABORATORY INVESTIGATION, 1998, 78 (01) : 8A - 8A
  • [2] Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours
    Tos, APD
    Doglioni, C
    Piccinin, S
    Sciot, R
    Furlanetto, A
    Boiocchi, M
    Dal Cin, P
    Maestro, R
    Fletcher, CDM
    Tallini, G
    [J]. JOURNAL OF PATHOLOGY, 2000, 190 (05): : 531 - 536
  • [3] Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Alshenawy, Hanan
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (06) : 1073 - 1081
  • [4] Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Hanan Alshenawy
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1073 - 1081
  • [5] Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/well differentiated liposarcoma
    Machado, Isidro
    Vargas, A. Cristina
    Maclean, Fiona
    Llombart-Bosch, Antonio
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 232
  • [6] Expression of HMGI-C and HMGI(Y) in lipoma and atypical lipomatous tumors: Immunohistochemical reactivity correlates with karyotypic alterations.
    Tallini, G
    DalCin, P
    Giancotti, V
    Fusco, A
    VandenBerghe, H
    Sciot, R
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 63 - 63
  • [7] Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors - Immunohistochemical reactivity correlates with karyotypic alterations
    Tallini, G
    DalCin, P
    Rhoden, KJ
    Chiapetta, G
    Manfioletti, G
    Giancotti, V
    Fusco, A
    VandenBerghe, H
    Sciot, R
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (01): : 37 - 43
  • [8] Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor
    Stojanov, Ivan J.
    Marino-Enriquez, Adrian
    Bahri, Nacef
    Jo, Vickie Y.
    Woo, Sook-Bin
    [J]. HEAD & NECK PATHOLOGY, 2019, 13 (02): : 169 - 176
  • [9] Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor
    Ivan J. Stojanov
    Adrian Mariño-Enriquez
    Nacef Bahri
    Vickie Y. Jo
    Sook-Bin Woo
    [J]. Head and Neck Pathology, 2019, 13 : 169 - 176
  • [10] MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors? A New Perspective
    Clay, Michael R.
    Martinez, Anthony P.
    Weiss, Sharon W.
    Edgar, Mark A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1647 - 1652
12345